You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HuMax IL-8

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Nivolumab, HuMax-IL8, Cabiralizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins University
Jul 28, 2022

PCO Trial in Peshawar (OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD), Metformin (1000 mg Twice a day))

Recruiting
  • PCO
  • OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD)
  • Metformin (1000 mg Twice a day)
  • Peshawar, Khyber Pakhtunkhwa, Pakistan
    Gynecology and Obstetric, Hayatabad Medical Complex
Jul 19, 2023

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023

Periodontitis Trial in Rize (biochemical analysis)

Completed
  • Periodontitis
  • biochemical analysis
  • Rize, Turkey
    Recep Tayyip Erdogan University
Oct 18, 2023

Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

Not yet recruiting
  • Glioblastoma
  • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
  • Gainesville, Florida
    University of Florida Health
Jul 29, 2022

Apical Periodontitis Trial in Giza (Root canal instrumentation, 2.5% NaOCl irrigation)

Completed
  • Apical Periodontitis
  • Root canal instrumentation, 2.5% NaOCl irrigation
  • Giza, Egypt
    Faculty of Dentistry, Cairo University
Jan 18, 2023

Rheumatoid Arthritis Trial (F8IL10)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Nov 10, 2022

IL-8+ naïve T Cells as a Biomarker for Thymoma Identification

Not yet recruiting
  • Thymoma
  • level of IL-8+ initial T cells
  • (no location specified)
Jul 23, 2022

IL6&8 in Malnourished Children With Acute Diarrhea

Not yet recruiting
  • Acute Diarrhea
  • +2 more
  • Evaluation of serum levels of IL-6 and IL-8
  • Sohag, Egypt
    Sohag University Hospital
Dec 21, 2021

Serum Interleukin 6 and 8 in Children With Acute Gastroenteritis

Recruiting
  • Acute Gastroenteritis
  • Acute Diarrhea
  • Evaluation of serum levels of IL-6 and IL-8
  • Sohag, Egypt
    Sohag University Hospital
Jan 15, 2022

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • TransCon IL-2 β/γ
  • +4 more
  • Boston, Massachusetts
  • +7 more
Nov 16, 2022

Irreversible Pulpitis Trial (Irrigant concentration, NaOCI)

Not yet recruiting
  • Irreversible Pulpitis
  • Irrigant concentration
  • NaOCI
  • (no location specified)
Mar 11, 2022

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

Obstructive Sleep Apnea and Idiopathic Pulmonary Fibrosis

Recruiting
  • OSA，IPF
  • IL-17A,S100A8
  • Tianjin, China
    Tianjin Medical University General Hospital
Apr 20, 2023

Low Back Pain Trial in Islamabad (• Blood Markers CRP, TNFa, IL-6, IL-8, IL-1, and IL-1ß AND FIBRINOGEN)

Not yet recruiting
  • Low Back Pain
  • • Blood Markers CRP, TNFα, IL-6, IL-8, IL-1, and IL-1β AND FIBRINOGEN
  • Islamabad, Pakistan
    KRL Hospital
Feb 20, 2023

Nitrates and IL-8 in Barrett's Esophagus

Enrolling by invitation
  • Barrett Esophagus
  • Esophageal Adenocarcinoma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Mar 31, 2022

    Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +3 more
    • Aldesleukin
    • Pembrolizumab
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Aug 8, 2022

    Solid Tumor, Sars-CoV2, Hematological Malignancy Trial in New York (BMS-986253)

    Terminated
    • Solid Tumor
    • +2 more
    • New York, New York
      Columbia University Irving Medical Center
    Nov 18, 2021

    Colon Carcinoma Trial in Netherlands (Nivolumab, Ipilimumab, Celecoxib 200mg)

    Recruiting
    • Colon Carcinoma
    • Amsterdam, Netherlands
    • +5 more
    Jan 23, 2023

    Rheumatoid Arthritis Trial in China (IL-6R Monoclonal Antibody Injection 4mg/kg, IL-6R Monoclonal Antibody Injection 6mg/kg,

    Completed
    • Rheumatoid Arthritis
    • IL-6R Monoclonal Antibody Injection 4mg/kg
    • +3 more
    • Baoding, China
    • +4 more
    Feb 24, 2022

    NSCLC, Hepatocellular Carcinoma Trial in New York (Nivolumab, BMS-813160, BMS-986253)

    Recruiting
    • Non-small Cell Lung Cancer
    • Hepatocellular Carcinoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Oct 14, 2021

    Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

    Withdrawn
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Bintrafusp Alfa
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 2, 2022

    IL-17+ CD8 T Cells in Cancer Patients Trial in Taichung

    Completed
    • IL-17+ CD8 T Cells in Cancer Patients
      • Taichung, Taiwan
        China Medical University Hospital
      Jul 27, 2021

      HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

      Recruiting
      • HNSCC
      • +5 more
      • DP CD8 TIL
      • +2 more
      • Portland, Oregon
        Providence Portland Medical Center
      Jun 5, 2023

      Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)

      Active, not recruiting
      • Recurrent Plasma Cell Myeloma
      • +2 more
      • Daratumumab
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      Nov 22, 2022